Our results showed that the independent prognostic significance of high levels of CD34+CD38−CD123+ leukemic cells at diagnosis is also observed in older AML patients treated by intensive chemotherapy and could be used to stratify risk in those patients. Here, CD34 is linked to acute myeloid leukemia.